Lucas Ward
Stock Analyst at Ascendiant Capital
(0.47)
# 4,301
Out of 5,239 analysts
31
Total ratings
22.58%
Success rate
-36.46%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $5.5 → $3 | $0.73 | +313.11% | 6 | Apr 22, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $11 → $4.2 | $1.50 | +180.00% | 5 | Apr 9, 2026 | |
| ACON Aclarion | Maintains: Buy | $23 → $7 | $3.15 | +122.22% | 6 | Mar 25, 2026 | |
| HSCS HeartSciences | Maintains: Buy | $9.2 → $8 | $1.99 | +302.21% | 5 | Mar 24, 2026 | |
| LIQT LiqTech International | Maintains: Buy | $4.2 → $4.3 | $2.35 | +82.98% | 7 | Mar 10, 2026 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $135,000 → $108,000 | $0.96 | +11,220,679.22% | 2 | Jul 29, 2024 |
Vivos Therapeutics
Apr 22, 2026
Maintains: Buy
Price Target: $5.5 → $3
Current: $0.73
Upside: +313.11%
60 Degrees Pharmaceuticals
Apr 9, 2026
Maintains: Buy
Price Target: $11 → $4.2
Current: $1.50
Upside: +180.00%
Aclarion
Mar 25, 2026
Maintains: Buy
Price Target: $23 → $7
Current: $3.15
Upside: +122.22%
HeartSciences
Mar 24, 2026
Maintains: Buy
Price Target: $9.2 → $8
Current: $1.99
Upside: +302.21%
LiqTech International
Mar 10, 2026
Maintains: Buy
Price Target: $4.2 → $4.3
Current: $2.35
Upside: +82.98%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $135,000 → $108,000
Current: $0.96
Upside: +11,220,679.22%